Mazyar Shadman, MD MPH

Just published in @BloodJournal our @FredHutch investigator-initiated trial of CD20 CAR T in Waldenström macroglobulinemia—the largest reported CAR T series in WM.

Developed in Brian Till’s lab; I had the privilege of serving as PI.

The joy of bringing science from lab to clinic!

ashpublications.org/blood/article/…

@IWMF_WM

TTNT is a very relevant endpoint in #CLL but it is surprising to see that PFS data is not even reported in some #ASH26 abstracts!

It is now time to register for this exciting event at #ASH26

Register: Bit.ly/aioash26

@OncBrothers
@lymphomaphilia @SoniSmithMD @dbranderMD @VincentRK @DrHKantarjian

Just published in @BloodAdvances!

"CAR T-cell therapy referral patterns and utilization for relapsed/refractory large B-cell lymphoma in the United States"
Only ~15% of patients receive CAR T.
We need to continue generating data, raising awareness, and improving access and utilization.

ashpublications.org/bloodadvances/…

Thanks to all the authors and collaborators at @bmsnews

@lymphomaphilia @KrishPatelMD @LNastoupilMD @mana1981

“There is nothing quite so useless as doing with great efficiency something that should not be done at all.”
-Peter Drucker

#Healthcare #HealthSystems #HealthcareLeadership